[go: up one dir, main page]

KR850002974A - 설펜아마이드 유도체의 제조방법 - Google Patents

설펜아마이드 유도체의 제조방법 Download PDF

Info

Publication number
KR850002974A
KR850002974A KR1019840006045A KR840006045A KR850002974A KR 850002974 A KR850002974 A KR 850002974A KR 1019840006045 A KR1019840006045 A KR 1019840006045A KR 840006045 A KR840006045 A KR 840006045A KR 850002974 A KR850002974 A KR 850002974A
Authority
KR
South Korea
Prior art keywords
following formula
preparing
usable salt
sulfenamide derivative
ring
Prior art date
Application number
KR1019840006045A
Other languages
English (en)
Inventor
쉭카네더 헬무트 (외 5)
Original Assignee
쿠르트 레닝 아렌스,레인홀트 포트만
루드비히 호이만 운트 코. 게엠바하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쿠르트 레닝 아렌스,레인홀트 포트만, 루드비히 호이만 운트 코. 게엠바하 filed Critical 쿠르트 레닝 아렌스,레인홀트 포트만
Publication of KR850002974A publication Critical patent/KR850002974A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

설펜아마이드 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 다음 구조식(Ⅱ)의 아민을 다음 구조식(Ⅲ의 설페닐할라이드 또는 다음 구조식(Ⅳ)의 설페닐산 할라이드와 염기촉매하게 반응시키고 얻어진 화합물을 임의로 그 생리적으로 사용가능한 염으로 전환시킴을 특징으로 하는 구조식(Ⅰ)의 설펜아마이드 유도체 또는 그 생리적으로 사용 가능한 염을 제조하는 방법.
    상기식에서, R1은 수소원자이며, R2는 C1-C6의 직쇄상 또는 측쇄상 알킬 또는 C5-C6사이클로알킬기이거나, 또는 비치환 또는 모노-내지 트리-치환의 아릴 또는 헤테로아릴기이거나, 또는 R1과 R2가 함께 이소티아졸린 환 또는 이소티아졸리논 환을 형성하며, Hal은 염소 또는 취소이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840006045A 1983-10-06 1984-09-29 설펜아마이드 유도체의 제조방법 KR850002974A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833336410 DE3336410A1 (de) 1983-10-06 1983-10-06 Sulfenamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3336410.9 1983-10-16

Publications (1)

Publication Number Publication Date
KR850002974A true KR850002974A (ko) 1985-05-28

Family

ID=6211186

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840006045A KR850002974A (ko) 1983-10-06 1984-09-29 설펜아마이드 유도체의 제조방법

Country Status (14)

Country Link
EP (1) EP0141119A3 (ko)
JP (1) JPS60100562A (ko)
KR (1) KR850002974A (ko)
AU (1) AU3268284A (ko)
DE (1) DE3336410A1 (ko)
DK (1) DK451784A (ko)
ES (1) ES8505996A1 (ko)
GR (1) GR80476B (ko)
HU (1) HUT35667A (ko)
IL (1) IL72855A0 (ko)
NZ (1) NZ209707A (ko)
PT (1) PT79288A (ko)
YU (1) YU168384A (ko)
ZA (1) ZA846898B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193253B (en) * 1985-01-29 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing 3,5-diamino-1,2,4-triazole derivatives
CA2461557A1 (en) * 2001-10-16 2003-04-24 University Of Kansas Novel prodrugs of n-h bond-containing compounds and methods of making thereof
CN103058958A (zh) * 2011-10-22 2013-04-24 杭州福斯特药业有限公司 一种罗沙替丁醋酸酯盐酸盐的合成方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
AU538818B2 (en) * 1979-10-22 1984-08-30 Glaxo Group Limited 1-h-1,2,4-triazole compounds
JPS5775976A (en) * 1980-08-27 1982-05-12 Glaxo Group Ltd Novel heterocyclic derivative, manufacture and medicinal composition containing same
ES520031A0 (es) * 1982-02-24 1984-04-01 Glaxo Group Ltd Un procedimiento para prepararacion de derivados del triazol.

Also Published As

Publication number Publication date
DE3336410A1 (de) 1985-04-18
YU168384A (en) 1986-10-31
PT79288A (de) 1984-11-01
DK451784D0 (da) 1984-09-21
JPS60100562A (ja) 1985-06-04
ES536305A0 (es) 1985-07-01
NZ209707A (en) 1986-11-12
HUT35667A (en) 1985-07-29
AU3268284A (en) 1985-05-02
EP0141119A2 (de) 1985-05-15
DK451784A (da) 1985-04-07
ES8505996A1 (es) 1985-07-01
IL72855A0 (en) 1984-12-31
GR80476B (en) 1985-02-07
ZA846898B (en) 1985-04-24
EP0141119A3 (de) 1988-02-03

Similar Documents

Publication Publication Date Title
KR890005084A (ko) 퀴놀린 유도체
KR850002974A (ko) 설펜아마이드 유도체의 제조방법
KR870000296A (ko) 신규한 이사틴 화합물의 제조방법
KR830006302A (ko) 신규 피리미딘 유도체의 제조방법
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR850004587A (ko) 치환된 n-페닐-n'-아실이소티오우레아의 제조방법
KR890008151A (ko) 키놀린 카르복산의 유도체
KR840004123A (ko) 포스포리피드 유도체의 제조방법
KR830009076A (ko) 3,5-디-3급-부틸-4-하이드록시페닐-치환 복소환 화합물의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR870008840A (ko) 1-스티렌술포닐-2-옥소-5-히드록시 피롤리딘 유도체의 제조방법
KR850006406A (ko) 4,7-디히드로피라졸[3,4-b] 피리딘 유도체의 제조방법
KR830005161A (ko) 유기화합물 또는 관련 유기화합물의 개선
KR840000504A (ko) N- 페닐피라졸 유도체의 제조방법
KR840001150A (ko) 치환페닐(티오노)카바메이트의 제조방법
KR840005721A (ko) 치환된 1,3,4-벤조트리아제핀의 제조방법
KR830004276A (ko) 5-아미노-1,2,3-티아디아졸의 제조방법
KR850005450A (ko) N-포스포릴-또는 n-티오포스포릴-n'-s-트리아지닐-포름아미딘의 제조방법
KR850004588A (ko) 2-티오시아나토-벤즈아미드의 제조방법
KR840002369A (ko) 1-(3,4,5-트리메톡시신나모일)-4-아미노카르보닐에틸 치환 피페라진 유도체 및 그 제법
KR870002155A (ko) 디아자포스포린의 제조방법
KR830004231A (ko) 2,5-디알킬 펜일 우레아 유도체들의 제조방법
KR890002190A (ko) 퀴놀린 카르본산 유도체
KR830005193A (ko) 5-설파모일-오르타닐산의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19840929

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid